Nuclear Power Department III carries out imports / exports of radioisotopes (mainly Co60) and related equipment, as well as arrangement / coordination of radioactive material transportation (including nuclear fuels for Japanese power companies). In cooperation with the overseas footholds of Marubeni group, we also conduct new development projects in the area of nuclear research and energy-saving.
We are the exclusive Co-60 distributor in Japan for Nordion (Canada) Inc., the largest Co-60 supplier in the world. Co-60 plays an important role in our daily lives. It is widely used in a number of areas, such as sterilization of medical equipment, radiotherapy R&D, and material reformation.
We also handle other special radioisotopes and stable isotopes from foreign suppliers, which are used for R&D purposes.
We exclusively handle Canadian research irradiators (Gammacell 1000 Elite, Gammacell 3000 Elan, Gammacell 40 Exactor) for universities, medical institutions, and pharmaceuticals.
In addition, we have also been commissioned to perform maintenance on Gammacell irradiators, relocate them to Japan, and return them to Best Theratronics, Ltd.
We provide transportation support services to maintain a stable supply of nuclear fuel imported from the United States and Europe to nuclear power plants in Japan.
Through our transportation services, we work hard to ensure that nuclear fuel is transported safely and securely. This is achieved by coordinating transportation companies with ocean-going shipping lines and overland transportation companies in Japan and other countries.
Dawonsys Co., Ltd., based in Ansan, Korea, is a rapidly growing manufacturer of large current power supply with high performance/high quality products. Their main products include large current power supply for fusion reactors, electromagnets for accelerators, modulator power supply for Klystron with track records of supply to KSTAR(Korea Superconducting Tokamak Advanced Research), PAL(Pohang Accelerator Research) and iBNCT(Ibaraki Boron Neutron Capture Therapy project at Ibaraki, Japan).